Srihari S. Naidu MD, MSCAI, FACC, FAHA, Editor of Hypertrophic Cardiomyopathy is a Professor of Medicine at New York Medical College, and Director of the Hypertrophic Cardiomyopathy Center and Cardiac Catheterization Laboratories at Westchester Medical Center Health Network in Valhalla, New York. He completed training in internal medicine at New York Presbyterian Hospital - Cornell Medical Center and general and interventional cardiology at the University of Pennsylvania Medical Center.A recognized expert in the management of patients with Hypertrophic Cardiomyopathy in general, and the minimally-invasive alternative to open heart surgery alcohol septal ablation in particular, Dr. Naidu runs one of the largest, comprehensive, multi-disciplinary Hypertrophic Cardiomyopathy Centers of Excellence and has managed over 3000 patients with the disease. The author of over 250 original manuscripts and 4 books, including the children’s book “Lindsay’s Big Heart”, Dr. Naidu is renowned throughout the United States and Europe for his work on Hypertrophic Cardiomyopathy and Interventional Cardiology, including running a live national proctoring course on the alcohol septal ablation technique.A nationally regarded cardiologist, Dr. Naidu serves on several committees within the American College of Cardiology (ACC) and rose to Board Member of its Board of Governors from 2021-2024.  He has co-authored or chaired 6 national guidelines and consensus statements, including two on Hypertrophic Cardiomyopathy, for the American Heart Association and the American College of Cardiology.  Dr. Naidu is a Former Trustee of the Society for Cardiovascular Angiography and Interventions (SCAI) and currently serves as its President from 2025-2026. Within SCAI, he founded the Emerging Leader Mentorship (ELM) Program, an executive leadership track for promising early career interventional cardiologists, and was instrumental in creating a universal definition for cardiogenic shock, now the standard around the world. A graduate of Brown University for both college and medical school, Dr. Naidu is Past President of the Brown Medical School Board of Directors and Trustee Emeritus of the Brown University Corporation, Brown’s highest governing body.

• Natural History of Hypertrophic Cardiomyopathy.- Pathology and Pathophysiology.- Genetics of HCM and Role of Genetic Testing.- Family Screening and Cascade Testing.- Epiphenomena in Hypertrophic Cardiomyopathy: Acquired von Willebrand Syndrome.- Acute left ventricular ballooning in obstructive hypertrophic cardiomyopathy.- Epicardial and Microvascular Ischemia: Implications, Diagnosis, and Management.- Approach to Diagnosis: Echocardiography.- Cardiac MRI in Diagnosis and Management.- Phenocopies of HCM.- Assessment of Heart Failure and Angina: Invasive and Non-invasive Methods.- Assessment of Syncope.- Pediatric Diagnosis and Management.- Sudden Cardiac Death Risk Assessment.- Youth and Athletic Screening: Rationale, Methods, and Outcome.- Lifestyle Modification: Exercise and Sports.- Lifestyle Modification: Exercise and Sports.- Diet, Nutrition, and Managing Obesity.- Traditional Medical Therapy.- Hypertension and Hypertrophic Cardiomyopathy.- Diagnosing and Managing Pulmonary and Right-Sided Heart Disease: Pulmonary Hypertension, Right Ventricular Outflow Pathology, and Sleep Apnea.- Indications and Outcome of PPM and ICD Placement.- Management of Arrhythmia.- Indications for and Individualization of Septal Reduction Therapy.- Surgical Myectomy and Novel Surgical Techniques.- Alcohol Septal Ablation and Novel Interventional Techniques.- Managing the Critical Patient with HCM.- End-Stage Diastolic and Systolic Heart Failure.- End-Stage Diastolic and Systolic Heart Failure.- Cardiac Myosin Inhibitors and Future Directions in Medical Therapy.- Approach to the Initial and Follow-Up Visits.- Evaluation and Management of Hypertrophic Cardiomyopathic Patients Through Noncardiac Surgery and Pregnancy.- Building a Hypertrophic Cardiomyopathy Center of Excellence.- Professional and Patient-Related Support Groups and Advocacy.- Professional and Patient-Related Support Groups and Advocacy.- Longitudinal Case-Based Presentations in HCM.

Srihari S. Naidu MD, MSCAI, FACC, FAHA, Editor of Hypertrophic Cardiomyopathy is a Professor of Medicine at New York Medical College, and Director of the Hypertrophic Cardiomyopathy Center and Cardiac Catheterization Laboratories at Westchester Medical Center Health Network in Valhalla, New York. He completed training in internal medicine at New York Presbyterian Hospital - Cornell Medical Center and general and interventional cardiology at the University of Pennsylvania Medical Center.A recognized expert in the management of patients with Hypertrophic Cardiomyopathy in general, and the minimally-invasive alternative to open heart surgery alcohol septal ablation in particular, Dr. Naidu runs one of the largest, comprehensive, multi-disciplinary Hypertrophic Cardiomyopathy Centers of Excellence and has managed over 3000 patients with the disease. The author of over 250 original manuscripts and 4 books, including the children’s book “Lindsay’s Big Heart”, Dr. Naidu is renowned throughout the United States and Europe for his work on Hypertrophic Cardiomyopathy and Interventional Cardiology, including running a live national proctoring course on the alcohol septal ablation technique.A nationally regarded cardiologist, Dr. Naidu serves on several committees within the American College of Cardiology (ACC) and rose to Board Member of its Board of Governors from 2021-2024.  He has co-authored or chaired 6 national guidelines and consensus statements, including two on Hypertrophic Cardiomyopathy, for the American Heart Association and the American College of Cardiology.  Dr. Naidu is a Former Trustee of the Society for Cardiovascular Angiography and Interventions (SCAI) and currently serves as its President from 2025-2026. Within SCAI, he founded the Emerging Leader Mentorship (ELM) Program, an executive leadership track for promising early career interventional cardiologists, and was instrumental in creating a universal definition for cardiogenic shock, now the standard around the world. A graduate of Brown University for both college and medical school, Dr. Naidu is Past President of the Brown Medical School Board of Directors and Trustee Emeritus of the Brown University Corporation, Brown’s highest governing body.

• Natural History of Hypertrophic Cardiomyopathy.- Pathology and Pathophysiology.- Genetics of HCM and Role of Genetic Testing.- Family Screening and Cascade Testing.- Epiphenomena in Hypertrophic Cardiomyopathy: Acquired von Willebrand Syndrome.- Acute left ventricular ballooning in obstructive hypertrophic cardiomyopathy.- Epicardial and Microvascular Ischemia: Implications, Diagnosis, and Management.- Approach to Diagnosis: Echocardiography.- Cardiac MRI in Diagnosis and Management.- Phenocopies of HCM.- Assessment of Heart Failure and Angina: Invasive and Non-invasive Methods.- Assessment of Syncope.- Pediatric Diagnosis and Management.- Sudden Cardiac Death Risk Assessment.- Youth and Athletic Screening: Rationale, Methods, and Outcome.- Lifestyle Modification: Exercise and Sports.- Lifestyle Modification: Exercise and Sports.- Diet, Nutrition, and Managing Obesity.- Traditional Medical Therapy.- Hypertension and Hypertrophic Cardiomyopathy.- Diagnosing and Managing Pulmonary and Right-Sided Heart Disease: Pulmonary Hypertension, Right Ventricular Outflow Pathology, and Sleep Apnea.- Indications and Outcome of PPM and ICD Placement.- Management of Arrhythmia.- Indications for and Individualization of Septal Reduction Therapy.- Surgical Myectomy and Novel Surgical Techniques.- Alcohol Septal Ablation and Novel Interventional Techniques.- Managing the Critical Patient with HCM.- End-Stage Diastolic and Systolic Heart Failure.- End-Stage Diastolic and Systolic Heart Failure.- Cardiac Myosin Inhibitors and Future Directions in Medical Therapy.- Approach to the Initial and Follow-Up Visits.- Evaluation and Management of Hypertrophic Cardiomyopathic Patients Through Noncardiac Surgery and Pregnancy.- Building a Hypertrophic Cardiomyopathy Center of Excellence.- Professional and Patient-Related Support Groups and Advocacy.- Professional and Patient-Related Support Groups and Advocacy.- Longitudinal Case-Based Presentations in HCM.

Srihari S. Naidu MD, MSCAI, FACC, FAHA, Editor of Hypertrophic Cardiomyopathy is a Professor of Medicine at New York Medical College, and Director of the Hypertrophic Cardiomyopathy Center and Cardiac Catheterization Laboratories at Westchester Medical Center Health Network in Valhalla, New York. He completed training in internal medicine at New York Presbyterian Hospital - Cornell Medical Center and general and interventional cardiology at the University of Pennsylvania Medical Center.A recognized expert in the management of patients with Hypertrophic Cardiomyopathy in general, and the minimally-invasive alternative to open heart surgery alcohol septal ablation in particular, Dr. Naidu runs one of the largest, comprehensive, multi-disciplinary Hypertrophic Cardiomyopathy Centers of Excellence and has managed over 3000 patients with the disease. The author of over 250 original manuscripts and 4 books, including the children’s book “Lindsay’s Big Heart”, Dr. Naidu is renowned throughout the United States and Europe for his work on Hypertrophic Cardiomyopathy and Interventional Cardiology, including running a live national proctoring course on the alcohol septal ablation technique.A nationally regarded cardiologist, Dr. Naidu serves on several committees within the American College of Cardiology (ACC) and rose to Board Member of its Board of Governors from 2021-2024.  He has co-authored or chaired 6 national guidelines and consensus statements, including two on Hypertrophic Cardiomyopathy, for the American Heart Association and the American College of Cardiology.  Dr. Naidu is a Former Trustee of the Society for Cardiovascular Angiography and Interventions (SCAI) and currently serves as its President from 2025-2026. Within SCAI, he founded the Emerging Leader Mentorship (ELM) Program, an executive leadership track for promising early career interventional cardiologists, and was instrumental in creating a universal definition for cardiogenic shock, now the standard around the world. A graduate of Brown University for both college and medical school, Dr. Naidu is Past President of the Brown Medical School Board of Directors and Trustee Emeritus of the Brown University Corporation, Brown’s highest governing body.

• Natural History of Hypertrophic Cardiomyopathy.- Pathology and Pathophysiology.- Genetics of HCM and Role of Genetic Testing.- Family Screening and Cascade Testing.- Epiphenomena in Hypertrophic Cardiomyopathy: Acquired von Willebrand Syndrome.- Acute left ventricular ballooning in obstructive hypertrophic cardiomyopathy.- Epicardial and Microvascular Ischemia: Implications, Diagnosis, and Management.- Approach to Diagnosis: Echocardiography.- Cardiac MRI in Diagnosis and Management.- Phenocopies of HCM.- Assessment of Heart Failure and Angina: Invasive and Non-invasive Methods.- Assessment of Syncope.- Pediatric Diagnosis and Management.- Sudden Cardiac Death Risk Assessment.- Youth and Athletic Screening: Rationale, Methods, and Outcome.- Lifestyle Modification: Exercise and Sports.- Lifestyle Modification: Exercise and Sports.- Diet, Nutrition, and Managing Obesity.- Traditional Medical Therapy.- Hypertension and Hypertrophic Cardiomyopathy.- Diagnosing and Managing Pulmonary and Right-Sided Heart Disease: Pulmonary Hypertension, Right Ventricular Outflow Pathology, and Sleep Apnea.- Indications and Outcome of PPM and ICD Placement.- Management of Arrhythmia.- Indications for and Individualization of Septal Reduction Therapy.- Surgical Myectomy and Novel Surgical Techniques.- Alcohol Septal Ablation and Novel Interventional Techniques.- Managing the Critical Patient with HCM.- End-Stage Diastolic and Systolic Heart Failure.- End-Stage Diastolic and Systolic Heart Failure.- Cardiac Myosin Inhibitors and Future Directions in Medical Therapy.- Approach to the Initial and Follow-Up Visits.- Evaluation and Management of Hypertrophic Cardiomyopathic Patients Through Noncardiac Surgery and Pregnancy.- Building a Hypertrophic Cardiomyopathy Center of Excellence.- Professional and Patient-Related Support Groups and Advocacy.- Professional and Patient-Related Support Groups and Advocacy.- Longitudinal Case-Based Presentations in HCM.